期刊
CELL DEATH AND DIFFERENTIATION
卷 28, 期 1, 页码 267-282出版社
SPRINGERNATURE
DOI: 10.1038/s41418-020-0599-8
关键词
-
资金
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Canadian Cancer Society (CCS)
- Breast Cancer Society of Canada (BCSC)
- Calgary Centre for Cancer Research (CCCR)
- National Institutes of Health (NIH) [NS041021]
- Charbonneau Cancer Institute Director's Award for Excellence in Research Productivity from the University of Calgary
- Eyes High International Doctoral Scholarship from the University of Calgary
- William H Davies Medical Research Scholarship from the University of Calgary
- Achievers in Medical Science (AIMS) Graduate Recruitment Scholarship from the University of Calgary
- Eyes High Recruitment Award from the University of Calgary
- University of Calgary
Studies show that SUMO E3 ligases PIAS1 and TIF1γ collaborate to promote the SUMOylation of SnoN, suppressing EMT in breast cell-derived tissue organoids. These E3 ligases act in an interdependent manner in the regulation process.
SUMO E3 ligases specify protein substrates for SUMOylation. The SUMO E3 ligases PIAS1 and TIF1 gamma target the transcriptional regulator SnoN for SUMOylation leading to suppression of epithelial-mesenchymal transition (EMT). Whether and how TIF1 gamma and PIAS1 might coordinate SnoN SUMOylation and regulation of EMT remained unknown. Here, we reveal that SnoN associates simultaneously with both TIF1 gamma and PIAS1, leading to a trimeric protein complex. Hence, PIAS1 and TIF1 gamma collaborate to promote the SUMOylation of SnoN. Importantly, loss of function studies of PIAS1 and TIF1 gamma suggest that these E3 ligases act in an interdependent manner to suppress EMT of breast cell-derived tissue organoids. Collectively, our findings unveil a novel mechanism by which SUMO E3 ligases coordinate substrate SUMOylation with biological implications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据